Picture of Biotalys NV logo

BTLS — Biotalys NV News Story

0.000.00%
be flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeSmall CapSucker Stock

Brief: Biotalys Shares Update On Latest Global Field Trials Of First Biocontrol

May 31 (Reuters) - Biotalys NV  BTLS.BR :
    * BIOTALYS CONTINUES TO DEMONSTRATE STRENGTH OF FIRST
BIOCONTROL
IN LATEST GLOBAL FIELD TRIALS
    * TRIALS CONTINUE TO SHOWCASE EFFICACY OF BIOTALYS' FIRST
PROTEIN-BASED BIOCONTROL EVOCA™ ACROSS VARIOUS HIGH-VALUE CROPS
    * FOLLOWING REGULATORY APPROVAL, FRUIT AND VEGETABLE GROWERS
WILL
BE ABLE TO USE EVOCA AS A NOVEL, SAFE AND SUSTAINABLE CROP
PROTECTION TOOL
    * TODAY REVEALED INITIAL RESULTS OF ITS LATEST FIELD TRIALS
FOR
ITS FIRST BIOCONTROL, EVOCA*
    * AS IN PREVIOUS YEARS, 2022 FIELD TRIALS SHOWED EXCELLENT
RESULTS
FOR USE OF EVOCA AGAINST BOTRYTIS IN GRAPES

Source text for Eikon:  ID:nGNE37ZFFD 
Further company coverage:  BTLS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))

Recent news on Biotalys NV

See all news